Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
JAMA Dermatology, 2023.
Ali Al-Janabi; Oras A. Alabas; Zenas Z. N. Yiu; Amy C. Foulkes; Steve Eyre; Adnan R. Khan; Nick J. Reynolds; Catherine H. Smith; Christopher E. M. Griffiths; Richard B. Warren; the BADBIR Study Group.
Read publication: JAMA Dermatology
Related
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic ...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
0 Comments